![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
![A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/36268859-1d67-4a34-b9e2-1ba725804c4d/cncr34352-fig-0001-m.png)
A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library
![Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2022/op.2022.18.issue-3/op.21.00482/20220303/images/large/op.21.00482t1.jpeg)
Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice
![Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-26/jco.19.00647/20190827/images/large/jco.19.00647ta1.jpeg)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology
![A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology](https://www.thelancet.com/cms/attachment/fe468876-c413-4818-b918-0f871d688eda/gr1_lrg.jpg)
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology
![Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00296-8/MediaObjects/41523_2021_296_Fig1_HTML.png)
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer
![Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-09710-8/MediaObjects/10434_2021_9710_Fig1_HTML.png)
Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator | SpringerLink
![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub](https://www.pdffiller.com/preview/428/167/428167845/large.png)
The Treatment Plan and Summary provide a brief record of major aspects of breast cancer adjuvant treatment: Fill out & sign online | DocHub
![Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda](https://integrativeoncology-essentials.com/wp-content/uploads/2019/03/Screen-Shot-2019-03-28-at-11.39.28-AM-519x1024.png)
Breast Cancer Basics: Hormonal Therapy (How To Decide If You Should You Take It For 5 Or 10 Years) – IOE Program by Dr. Brian Lawenda
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr2.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
A Risk‑benefit Assessment Approach to Selection of Adjuvant Chemotherapy in Elderly Patients with Early Breast Cancer: A Mini
![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
![Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid | BMC Health Services Research | Full Text Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid | BMC Health Services Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12913-019-3988-2/MediaObjects/12913_2019_3988_Fig1_HTML.png)